Patent directory · USPTO A61K / A61P
Patents matching “THE REGENTS OF THE UNIVERSITY OF MICHIGAN”
774 pharma patents match "THE REGENTS OF THE UNIVERSITY OF MICHIGAN" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 774 pharmaceutical patents matching "THE REGENTS OF THE UNIVERSITY OF MICHIGAN" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 9132210
Scaffolds for cell transplantation
granted -
US 9128093
Selective cytopheresis devices and related methods thereof
granted -
US 9126978
1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
granted -
US 9120744
Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid metabolism
granted -
US 9107883
Compounds and methods for treating aberrant adrenocartical cell disorders
granted -
US 9107940
Compositions and methods for treating and preventing skeletal muscle deficiencies
granted -
US 9096625
BCL-2/BCL-XL inhibitors and therapeutic methods using the same
granted -
US 9096501
Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid metabolism
granted -
US 9089556
Method for treating cancer using an antibody that inhibits notch4 signaling
granted -
US 9079913
Spiro-oxindole MDM2 antagonists
granted -
US 9062093
Peptide compositions and methods for treating patients
granted -
US 9057054
Antigen-specific long-term memory T-cells
granted -
US 9045526
Compound and method for modulating opioid receptor activity
granted -
US 9029502
Inhibitors of the epidermal growth factor receptor-heat shock protein 90 binding interaction
granted -
US 9023798
Cystinosin replacement factor
granted -
US 9017644
Methods of treating autoimmune disorders and/or inflammatory disorders
granted -
US 8993552
Compositions and methods for treatment of leukemia
granted -
US 8980838
Cyclized peptidomimetic small molecule inhibitors of the WDR5 and MLL1 interaction
granted -
US 8980907
Dendrimer conjugates
granted -
US 8975029
Integrin alpha-2 binding agents and use thereof to inhibit cancer cell proliferation
granted -
US 8975293
Epigenetic co-repressors of the gamma-globin gene and methods of using same
granted -
US 8962026
Nanoemulsion therapeutic compositions and methods of using the same
granted -
US 8961959
Glucosylceramide synthase inhibitors and therapeutic methods using the same
granted -
US 8946424
Deuterated amlexanox
granted